Literature DB >> 29649504

Tau pathology and neurochemical changes associated with memory dysfunction in an optimised murine model of global cerebral ischaemia - A potential model for vascular dementia?

Sabah Khan1, Nadira Y Yuldasheva1, Trevor F C Batten2, Alasdair R Pickles3, Katherine A B Kellett4, Sikha Saha5.   

Abstract

Cerebral ischemia is known to be a major cause of death and the later development of Alzheimer's disease and vascular dementia. However, ischemia induced cellular damage that initiates these diseases remain poorly understood. This is primarily due to lack of clinically relevant models that are highly reproducible. Here, we have optimised a murine model of global cerebral ischaemia with multiple markers to determine brain pathology, neurochemistry and correlated memory deficits in these animals. Cerebral ischaemia in mice was induced by bilateral common carotid artery occlusion. Following reperfusion, the mice were either fixed with 4% paraformaldehyde or decapitated under anaesthesia. Brains were processed for Western blotting or immunohistochemistry for glial (GLT1) and vesicular (VGLUT1, VGLUT2) glutamate transporters and paired helical filament (PHF1) tau. The PHF1 tau is the main component of neurofibrillary tangle, which is the pathological hallmark of Alzheimer's disease and vascular dementia. The novel object recognition behavioural assay was used to investigate the functional cognitive consequences in these mice. The results show consistent and selective neuronal and glial cell changes in the hippocampus and the cortex together with significant reductions in GLT1 (***P < 0.001), VGLUT1 (**P < 0.01) and VGLUT2 (***P < 0.001) expressions in the hippocampus in occluded mice as compared to sham-operated animals. These changes are associated with increased PHF1 (***P < 0.0001) protein and a significant impairment of performance (*p < 0.0006, N = 6/group) in the novel object recognition test. This model represents a useful tool for investigating cellular, biochemical and molecular mechanisms of global cerebral ischaemia and may be an ideal preclinical model for vascular dementia.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glial cells; Global cerebral ischaemia; Glutamate transporter; Hippocampus; Memory deficit; Stroke; Tau protein; Vascular dementia

Mesh:

Substances:

Year:  2018        PMID: 29649504     DOI: 10.1016/j.neuint.2018.04.004

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  19 in total

Review 1.  Participation of Amyloid and Tau Protein in Neuronal Death and Neurodegeneration after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-06-28       Impact factor: 5.923

Review 2.  Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.

Authors:  Marzena Ułamek-Kozioł; Stanisław Jerzy Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-30       Impact factor: 5.923

3.  Tau as a potential therapeutic target for ischemic stroke.

Authors:  Xin Chen; Hua Jiang
Journal:  Aging (Albany NY)       Date:  2019-12-16       Impact factor: 5.682

4.  Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer's disease after 2 years of survival.

Authors:  Lidija Radenovic; Marija Nenadic; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar; Pavle R Andjus; Ryszard Pluta
Journal:  Aging (Albany NY)       Date:  2020-06-05       Impact factor: 5.955

Review 5.  Tau Protein Dysfunction after Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

6.  Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Janusz Kocki; Jacek Bogucki; Sławomir Januszewski; Anna Bogucka-Kocka; Stanisław J Czuczwar
Journal:  Mol Neurobiol       Date:  2019-11-12       Impact factor: 5.682

Review 7.  Shared Genomic and Proteomic Contribution of Amyloid and Tau Protein Characteristic of Alzheimer's Disease to Brain Ischemia.

Authors:  Ryszard Pluta; Marzena Ułamek-Kozioł; Sławomir Januszewski; Stanisław J Czuczwar
Journal:  Int J Mol Sci       Date:  2020-04-30       Impact factor: 6.208

Review 8.  Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia.

Authors:  Marzena Ułamek-Kozioł; Stanisław J Czuczwar; Sławomir Januszewski; Ryszard Pluta
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

Review 9.  Research progress on the role of type I vesicular glutamate transporter (VGLUT1) in nervous system diseases.

Authors:  Xianchao Du; Jiashuo Li; Minghui Li; Xinxin Yang; Zhipeng Qi; Bin Xu; Wei Liu; Zhaofa Xu; Yu Deng
Journal:  Cell Biosci       Date:  2020-03-04       Impact factor: 7.133

10.  Kinematic Changes in a Mouse Model of Penetrating Hippocampal Injury and Their Recovery After Intranasal Administration of Endometrial Mesenchymal Stem Cell-Derived Extracellular Vesicles.

Authors:  Lilia Carolina León-Moreno; Rolando Castañeda-Arellano; Irene Guadalupe Aguilar-García; María Fernanda Desentis-Desentis; Elizabeth Torres-Anguiano; Coral Estefanía Gutiérrez-Almeida; Luis Jesús Najar-Acosta; Gerardo Mendizabal-Ruiz; César Rodolfo Ascencio-Piña; Judith Marcela Dueñas-Jiménez; Jorge David Rivas-Carrillo; Sergio Horacio Dueñas-Jiménez
Journal:  Front Cell Neurosci       Date:  2020-09-10       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.